Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis

Journal of Experimental Medicine

Volumn 191, Issue 1, 2000, Pages 147-155

  Thomas, Christian A ^a,b,e   Li, Yongmei ^b   Kodama, Tatsuhiko ^c   Suzuki, Hiroshi ^c   Silverstein, Samuel C ^a,b   El Khoury, Joseph ^b,d,f  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gram positive bacteria; Macrophage; Phagocytosis; Scavenger receptor; Staphylococcus aureus

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; OPSONIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; INFECTION PREVENTION; INFECTION SENSITIVITY; KNOCKOUT MOUSE; LETHALITY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; GRAM-POSITIVE BACTERIAL INFECTIONS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OPSONIN PROTEINS; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS A; SCAVENGER RECEPTORS, CLASS B; STAPHYLOCOCCAL INFECTIONS; TEICHOIC ACIDS;

EID: 0034598314     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.1.147     Document Type: Article

References (60)

1. Silverstein, S.C., and T.H. Steinberg. 1989. Host defense against bacterial and fungal infections. In Microbiology. B.D. Davis, R. Dulbecco, H.N. Elsen, and H.S. Ginsberg, editors. J.B. Lippincott Company, Philadelphia. 485-505.
2. Wright, S.D., and S.C. Silverstein. 1986. Overview: the function of receptors in phagocytosis. In Cellular Immunology. D.M. Weir, editor. Blackwell Scientific Publications, Oxford/London/Edinburgh/Boston/Palo Alto/ Melbourne. 41.1-41.14.
3. Ofek, I., J. Keisari, and N. Sharon. 1995. Nonopsonic phagocytosis of microorganisms. Annu. Rev. Microbiol. 49:239-276.
4. Wessels, M.R., P. Butko, M. Ma, H.B. Warren, A.L. Lage, and M.C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA, 92: 11490-11494.
5. Prodeus, A.P., X. Zhou, M. Maurer, S.J. Galli, and M.C. Carroll. 1997. Impaired mast cell-dependent immunity in complement C3-deficient mice. Nature. 390:172-175.
6. Fischer, M.B., A.P. Prodeus, A. Nicholson-Weller, M. Ma, J. Murrow, R.R. Reid, H.B. Warren, A.L. Lage, F.D. Moore, Jr., and M.C. Carroll. 1997. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159:976-982.
7. Buckley, R.H. 1992. Immunodeficiency diseases. JAMA (J. Am. Med. Assoc.). 268:2797-2806.
8. von Behring, E., and S. Kitasato. 1890. Ueber das Zustande-Kommen der Diphterie Immunität und der Tetanus-Immunität bei Thierin. Dtsch. Med. Wochenschr. 16:113-114.
9. Bull, C.G. 1915. A method of serum treatment of pneumococcic septicemia in rabbits. J. Exp. Med. 22:466-475.
10. Briles, D.E., J.L. Clatlin, K. Schroer, and C. Forman. 1981. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature. 294:88-90.
11. Shapiro, E.D., and J.D. Clemens. 1984. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann. Intern. Med. 101:325-330.
12. Sanders, L.A.M., J.G.J. van de Winkel, G.T. Rijkers, M.M. Voorhorst-Ogink, M. de Haas, P.J.A. Capel, and B.J.M. Zegers. 1994. Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 170:854-861.
13. Platonov, A.E., E.J. Kuijper, I.V. Vershinina, G.A. Shipulin, N. Westerdaal, C.A. Fijen, and J.G. van de Winkel. 1998. Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component-deficient individuals. Clin. Exp. Immunol. 111:97-101.
14. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637.
15. Platt, N., H. Suzuki, Y. Kurihara, T. Kodama, and S. Gordon. 1996. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA. 93:12456-12460.
16. Goldstein, J.L., Y.K. Ho, S.K. Basu, and M.S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
17. Fraser, I., D. Hughes, and S. Gordon. 1993. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 364:343-346.
18. El Khoury, J., C.A. Thomas, J.D. Loike, L. Cao, and S.C. Silverstein. 1994. Macrophages adhere to glucose-modified collagen type IV via their scavenger receptors. J. Biol. Chem. 269:10197-10200.
19. El Khoury, J., S.E. Hickman, C.A. Thomas, L. Cao, S.C. Silverstein, and J.D. Loike. 1996. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils and secretion of reactive oxygen species. Nature. 382:716-719.
20. Hampton, R.Y., D.T. Golenbock, M. Penman, M. Krieger, and C.R.H. Raetz. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature. 352:342-344.
21. Dunne, D.W., D. Resnick, J. Greenberg, M. Krieger, and K.A. Joiner. 1994. The type I macrophage scavenger receptor binds gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA. 91:1863-1867.
22. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higasi, T. Suzuki, et al. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:292-296.
23. Haworth, R., N. Platt, S. Keshav, D. Hughes, E. Darley, H. Suzuki, Y. Kurihara, T. Kodama, and S. Gordon. 1997. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J. Exp. Med. 186:1431-1439.
24. Shanson, D.C. 1986. Staphylococcal infections in hospital. Brit. J. Hosp. Med. 35:312-320.
25. Brun-Buisson, C., F. Doyon, and J. Carlet. 1996. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am. J. Resp. Crit. Care Med. 154:617-624.
26. Sands, K.E., D.W. Bates, P.N. Lanken, P.S. Graman, P.L. Hibberd, K.L. Kahn, R. Panzer, E.J. Orav, D.R. Snydman, E. Black, et al. 1997. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA (J. Am. Med. Assoc.). 278:234-240.
27. Cohn, Z.A. 1962. Determinants of infection in the peritoneal cavity. I. Response to and fate of Staphylococcus aureus and Staphylococcus albus in the mouse. Yale J. Biol. Med. 35:12-28.
28. Cohn, Z.A. 1962. Determinants of infection in the peritoneal cavity. II. Factors influencing the fate of Staphylococcus aureus in the mouse. Yale J. Biol. Med. 35:29-47.
29. Cohn, Z.A. 1962. Determinants of infection in the peritoneal cavity. III. The action of selected inhibitors on the fate of Staphylococcus aureus in the mouse. Yale J. Biol. Med. 35:48-61.
30. Horwitz, M.A., and S.C. Silverstein. 1980. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J. Clin. Invest. 65: 82-94.
31. Brummer, E., J.G. McEwen, and D.A. Stevens. 1986. Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN. Clin. Exp. Immunol. 66:681-690.
32. Wan, C.P., C.S. Park, and B.H.S. Lau. 1993. A rapid and simple microfluorometric phagocytosis assay. J. Immunol. Methods. 162:1-7.
33. Loike, J.D., and S.C. Silverstein. 1983. A fluorescence quenching technique using trypan blue to differentiate between ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophages. J. Immunol. Methods. 57:373-379.
34. Sahlin, S., J. Hed, and I. Rundquist. 1983. Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorimetric assay. J. Immunol. Methods. 60:115-124.
35. Zimmerli, S., S. Edwards, and J.D. Ernst. 1996. Selective receptor blockade during phagocytosis does not alter survival and growth of Mycobacterium tuberculosis in human macrophages. Am. J. Respir. Cell Mol. Biol. 15:760-770.
36. Giaimis, J., Y. Lombard, P. Finteneau, C.D. Muller, R. Levy, M. Makaya-Kumba, J. Lazdins, and P. Poindron. 1993. Both mannose and beta-glucan receptors are involved in phagocytosis of unopsonized, heat killed Saccharomyces cerevisiae by murine macrophages. J. Leukoc. Biol. 54:564-571.
37. Ezekowitz, R., R.B. Sim, and S. Gordon. 1984. Local opsonization by secreted macrophage components. Role of receptors for complement in uptake of zymosan. J. Exp. Med. 159:244-260.
38. Wicken, A.J., and K.W. Knox. 1975. Lipoteichoic acids: a new class of bacterial antigen. Science. 187:1161-1167.
39. Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell. 80:603-609.
40. Endemann, G., L.W. Stanton, K.S. Madden, C.M. Bryant, R. Tyler-White, and A.A. Protter. 1993. CD36 is a receptor for oxidized LDL. J. Biol. Chem. 268:11811-11816.
41. Hughes, D.A., I.H. Frase, and S. Gordon. 1995. Murine macrophage scavenger receptor: in vivo expression and function for macrophage adhesion in lymphoid and non-lymphoid organs. Eur. J. Immunol. 25:466-473.
42. West, T.E., M.E. West, and J.M. Mylotte. 1985. Antiserum agar method for identification of Smith-type exopolysaccharides in clinical isolates of S. aureus. J. Clin. Microbiol. 21:490-492.
43. Verbrugh, H.A., W.F. Keane, J.R. Hoidal, M.R. Freiberg, and P.K. Peterson. 1983. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J. Infect. Dis. 147:1018-1029.
44. Melly, M.A., L.J. Duke, L. Deng-Fong, and J.H. Hash. 1974. Biological properties of the encapsulated Staphylococcus aureus M. Infect. Immun. 10:389-397.
45. Arizono, T., A. Umeda, and K. Amako. 1991. Distribution of capsular material on the cell wall surface of strain Smith diffuse of S. aureus. J. Bateriol. 173:4333-4340.
46. Peterson, P.K., B.J. Wilkinson, Y. Kim, D. Schmeling, and P.G. Quie. 1978. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 19:943-949.
47. Wilkinson, B.J., P.K. Peterson, and P.G. Quie. 1979. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect. Immun. 23:502-508.
48. Karakawa, W.W., A. Sutton, R. Schneerson, A. Karpas, and W.F. Vann. 1988. Capsular antibodies induce type-specific phagocytosis of encapsulated S. aureus by human polymorphonuclear leukocytes. Infect. Immun. 56:1090-1095.
49. Williams, J.D., and G.A. Coles. 1991. Gram-positive infections related to CAPD. J. Antimicrob. Chemother. 27(Suppl. B):31-35.
50. Saklayen, M.G. 1990. CAPD peritonitis. Incidence, pathogens, diagnosis, and management. Med. Clin. North Am. 74: 997-1010.
51. Carrozi, S., M.G. Nasini, A. Kunkl, S. Cantarella, and S. Lamperi. 1988. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy. ASAIO (Am. Soc. Artif. Intern. Organs) Trans. 34:635-639.
52. Carrozi, S., and S. Lamperi. 1988. Peritonitis prevention in CAPD. Clin. Nephrol. 30(Suppl. 1):S45-S48.
53. Lamperi, S., and S. Carozzi. 1988. Interferon-γ (IFN-γ) as in vitro enhancing factor of peritoneal macrophage defective-bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD). Am. J. Kidney Dis. 11:225-230.
54. deVilliers, W.J., I.P. Fraser, D.A. Hughes, A.G. Doyle, and S. Gordon. 1994. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180:705-709.
55. Fratazzi, C., R.D. Arbeit, C. Carini, and H.G. Remold. 1997. Programmed cell death of Mycobacterium arium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158: 4320-4327.
56. Rogers, H.W., M.P. Callery, B. Deck, and E.R. Unanue. 1996. Listeria monocytogenes induces apoptosis of infected hepatocytes. J. Immunol. 156:679-684.
57. Galvan, V., and B. Roizman. 1998. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. USA. 95: 3931-3936.
58. Rosen, H., S. Gordon, and R.J. North. 1989. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor on myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells. J. Exp. Mat. 170:27-37.
59. Irie, H., H. Koyama, A. Kubo, K. Fukuda, T. Aita, A. Koike, T. Yoshimura, J. Yoshida, J. Singa, and T. Hill. 1998. Herpes simplex virus hepatitis in macrophage-depleted mice: the role of massive, apoptotic cell death in pathogenesis. J. Gen. Virol. 79:1225-1231.
60. Pinto, A.J., D. Stewart, N. van Rooijen, and P.S. Morahan. 1991. Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphate: effects on antimicrobial resistance. J. Leukoc. Biol. 49:579-586.